Thyroxine, if not truly the active thyroid hormone ( 1, 2) is clearly the principal iodine-containing compound released by the thyroid gland, and ordinarily comprises the largest fraction of the plasma's protein-bound iodine (3-6). Many investigators have, therefore, attempted to assess thyroidal function by measuring the concentration of protein-bound I'll (PB1181) in the plasma following the administration of radioactive iodine (7-11). The PBI111 (12), or even the total radioactivity in the plasma (13, 14), determined several days after the administration of the tracer, reflects the radioactivity of circulating thyroxine, except in patients who have received large doses of 1181 (15) .
Thyroxine, if not truly the active thyroid hormone ( 1, 2) is clearly the principal iodine-containing compound released by the thyroid gland, and ordinarily comprises the largest fraction of the plasma's protein-bound iodine (3) (4) (5) (6) . Many investigators have, therefore, attempted to assess thyroidal function by measuring the concentration of protein-bound I'll (PB1181) in the plasma following the administration of radioactive iodine (7) (8) (9) (10) (11) . The PBI111 (12) , or even the total radioactivity in the plasma (13, 14) , determined several days after the administration of the tracer, reflects the radioactivity of circulating thyroxine, except in patients who have received large doses of 1181 (15) .
It has been shown that the hormonal iodine which is extractable from serum with butanol and not re-extractable with alkali (hereafter referred to as the butanol-extractable iodine) is composed largely of thyroxine. Its concentration in serum differs significantly from that of the protein-bound iodine (16) .
The present communication reports the results in 109 patients with varying states of thyroidal function in whom the plasma's concentration of radioactive butanol-extractable iodine was determined both one and three days after the administration of 181. From a correlation of these results with measurements of the amount of 11l8 accumulated by the thyroid gland, an estimate of both the amount and the rate of turnover of glandular hormone has been made.
MATERIALS AND METHODS
The present study includes all patients referred to the Department 24 -hour thyroidal uptake of radioactive iodine. Since no attempt was made to select cases within this group, which included dependents as well as military personnel, the population studied is probably representative of that referred to the thyroid clinic of any large hospital. Each patient was questioned and examined by one or another of the authors, and a diagnostic impression was recorded prior to the administration of I'. This record, together with the result of the iodineuptake test, was reviewed by one of the authors (S. H. I.), and each patient was assigned a definite diagnosis before the results of the butanol-extraction procedure were known. Prolonged observation of the patients, in an attempt to ascertain the accuracy of the diagnosis, was usually impossible.
A standard amount (50 to 100/Ac) of I', free of carrier, was administered orally to each patient. The patient returned 24 hours later for the determination of the thyroidal uptake of the tracer. This was carried out with a shielded Geiger-Mueller tube (bismuth-sputtered-cathode) placed 20 cm. from the neck. The radioactivity in the neck was compared with that of a 50 ml. volumetric flask, similarly positioned, containing an amount of I' equal to the dose administered. In most patients the thyroidal content of I' was also determined 48 and 72 hours after the administration of the tracer. The following convention was adopted as an index of the preponderance of either accumulation of radioiodine or the release of radioactive hormone during the interval between 24 and 72 hours after the administration of I'. When the thyroidal uptake displayed a progressive increase during this period, the 24-hour uptake was subtracted from the 72-hour uptake and the difference ("net change") was given a positive sign. When the uptake decreased at any time during the period, the lowest value was subtracted from the highest and the difference was given a negative sign.
During the 24 and 72-hour visits, blood was drawn for the measurement of the concentration of butanol-extractable I' (BEI'). Separation of the serum was carried out as soon as clot retraction had occurred. In virtually all cases, the analysis was begun on the same day the blood was drawn.
The method used in the extraction of thyroxine from serum was an adaptation of that described by Man, Kydd, and Peters (16 In the determination of the concentration of BEIG in erythrocytes, blood was drawn into a tube containing dried heparin. The erythrocytes were separated from the plasma and washed three times with normal saline solution. Five cc. of packed cells were laked with distilled water. Concomitant analyses for the concentration of BEIGE in plasma and laked erythrocytes were then carried out as above.
The radioactivity of the samples was measured with an end-windowed (mica 1.4 to 1.8 mg. per cm.') GeigerMueller tube and an automatic sample changer. At least 24,000 total counts were obtained for each serum sample. A correction, based on mass, was made in the observed radioactivity of each sample. Since, in the average euthyroid patient, the total thyroxine radioactivity in each sample of serum was approximately two-thirds of background radiation, approximately 9500 disintegrations were observed. The probable error of the determined radioactivity was therefore approximately 1 per cent. The accuracy of the counting procedure was considerably greater in hyperthyroid patients, in whom the concentration of radioactive thyroxine was usually markedly increased.
RESULTS
In an attempt to evaluate the analytic procedure described above, the recovery from serum of radioactive potassium iodide, diiodotyrosin,2 and thyroxine 2 was determined (Table I) . From 88 2 Obtained from Abbott Laboratories, Chicago, Illinois. to 97 per cent of radioiodine added as thyroxine was recovered from the final residue, whereas I131 added as either potassium iodide or diiodotyrosine was virtually excluded.
In both butanol-acetic acid-water and collidineammonia systems (17) , filter paper chromatography revealed that the radioactive material isolated from the serum of three patients who had received therapeutic doses of I'll moved precisely as did synthetic radiothyroxine. Both the material extracted from serum and synthetic radiothyroxine displayed small amounts of radioactivity with R.F.'s corresponding to those of iodide and diiodotyrosine. Degradation of thyroxine during the chromatographic procedure, leading to the appearance of similar fractions, has been previously described (17) .
The recovery from serum of triiodothyronine was not determined. Furthermore the chromatographic systems employed would probably not have permitted resolution of this material from thyroxine. The data, therefore, offer no evidence concerning the extent, if any, to which radioactive triiodothyronine contributed to the observed values of the BE151.
The concentration of BE115' was determined in the washed erythrocytes of three patients who had received therapeutic doses of radioactive iodine. Although simultaneously determined concentrations of BE1131 in the plasma were high, the radioactivity extracted from the erythrocytes was indistinguishable from background radiation (Table  II) . In all euthyroid and hyperthyroid patients, the concentration of BE115' in the serum increased during the interval between 24 and 72 hours after the administration of the tracer (Table III) . Patients with decreased thyroidal function associated with primary or pituitary myxedema, or with the ingestion of thyroid substance shall hereafter be referred to as patients with thyroidal inactivity. In this group of cases, significant differences between the 24 and 72 hour concentrations could not be detected. In five of six patients with carcinoma of the thyroid in whom total thyroidectomy had been attempted, and in two patients with thyrotoxicosis who continued to take propylthiouracil throughout the period of observation (not shown in Table III ) the 24-hour concentration of BEI111 exceeded that found at 72 hours.
The mean values of the BE1,1' concentrations in patients with thyrotoxicosis, euthyroidism, or thyroidal inactivity differed significantly from that found in the other two groups (p < .01), both at the 24-hour and at the 72-hour period. However, a better separation between the values found in patients with thyroidal inactivity, euthyroidism, and hyperthyroidism was found at the 72-hour period (Figure 1) In one patient (No. 96) with thyroidal inactivity, the BEI'11 value fell at the lower end of the normal range. This patient was a 36-year old male with non-toxic nodular goiter, who was receiving 2 gr. of dessicated thyroid substance daily, and whose 24-hour radioiodine uptake was 7 per cent.
In hyperthyroid patients, the mean net change in thyroidal uptake between 24 and 72-hours (-7.0 per cent) was significantly different (p < .01) from that found in euthyroid subjects (+ 0
The severity of thyrotoxicosis could not be consistently correlated with the pattern of consecutive neck counts. However, those patients with the most severe thyrotoxicosis generally demonstrated pattern 3, while those with the mildest disease displayed either pattern 1 or a small net loss of radioactivity of the type found in pattern 2.
In patients with decreased thyroidal function, the low level of radioactivity in the neck precluded the accurate measurement of progressive changes in the uptake of radioactive iodine. Nevertheless, it appeared certain that some thyroidal accumulation and storage of I'$' had occurred, since measureable radioactivity persisted in the region of the thyroid gland for several days.
Statistical correlations between the various functions studied are presented in Table IV . DISCUSSION Recovery experiments have demonstrated that the extraction procedure described is relatively specific for the principal iodine-containing compound in the plasma, thyroxine. In confirmation of previous reports, thyroxine has been found to be completely absent from the erythrocyte (18) .
Measurement of the concentration of radioactive thyroxine in the serum following the administration of a standard dose of radioiodine has been found to be a rather reliable guide to the state of thyroidal function in patients with thyrotoxicosis, euthyroidism, and thyroidal inactivity. In several patients who had undergone virtually complete thyroidectomy, however, the concentration of BE1118 did not correlate well with the clinical status of the patient. An explanation for this discrepancy was sought in an analysis of the factors determining the concentration of BEI'2' in the plasma.
The principal and perhaps only source of plasma's thyroxine appears to be the pool of hormonal iodine within the thyroid gland. Therefore, the relationship described by Zilversmit, Entenman, and Fishler for a product substance and its immediate precursor can be applied to the relationship existing between thyroxine in the plasma and in the thyroid gland (19) . These authors have demonstrated that when the precursor, and thence the product, is labelled with a radioactive component, the specific radioactivity (radioactive substance .A X/total substance X) of the precursor initially exceeds that of the product. The specific activity (S.A.) of the product then rises with a rapidity which is, at any time, proportional to the magnitude of the difference between the S.A.'s of the precursor and the product. The peak S. A. of the product is reached when the specific activities of the two have become equal. As the S.A. of the product exceeds that of the precursor, its own S.A. begins to decline. If it be assumed that the content of non-radioactive hormonal iodine in the thyroid gland and in the plasma remain constant during the period of observation, then changes in the radioactivity of the thyroid gland or of the plasma's BEI will be proportional to changes in their respective S.A.'s.
The concentration of hormonal iodine in the plasma of hyperthyroid patients is greater than normal (20, 21) . Nevertheless, in such patients following a tracer dose of 1181, the S.A. of the PBI increases more rapidly than normal (22) . The present findings suggest that the rate of increase of the S.A. of the BEI is also augmented in patients with thyrotoxicosis. In such patients, the S.A. of the glandular hormonal iodine must therefore exceed, at least initially, that found in patients with normal thyroidal function. The relatively greater S.A. of the thyrotoxic gland commonly results from an increase in the initial accumulation of Ill' and from a reduction in the total quantity of hormone stored within the gland (23) .
The "net change" in glandular radioactivity describes the direction and magnitude of changes in the S.A. of organically-bound iodine within the gland during the 24 to 72-hour interval. A decrease in the S.A. of the glandular hormone 8 was seen more often in thyrotoxic than in normal patients. The average thyroidal S.A. increased by 0.6 per cent in normal patients, but it decreased by 9 per cent in thyrotoxic patients. The more rapid loss of radioactivity from the thyroid glands of thyrotoxic patients results from an increase in the rapidity of disappearance of radioiodide from the plasma (24) which hastens the cessation of collection of radioiodine, and from an increase in the rate of turnover of glandular hormone, as will be seen below.
Thus in thyrotoxic patients, the S.A. of the ' The term "hormone," used in this sense, refers to all iodinated tyrosyl compounds within the gland. plasma's hormone is increasing and that of the glandular hormone is decreasing more rapidly than normal. The time interval required for the two to become equal and for the concentration of BEI181 to reach a peak, should therefore be shorter than normal in thyrotoxic patients. This proves to be the case when re-utilization of radioiodide made available by the peripheral degradation of hormone is prevented (22) . However, when as in the present study, re-utilization of radioiodide is allowed to occur, the decline in the S.A. of the glandular hormone is retarded, the peak concentration of the plasma's BE1118 is delayed, and its level increased.
In the patients "totally" thyroidectomized for thyroidal carcinoma, the concentration of BEI181 in the serum decreased during the interval between 24 and 72 hours after the administration of the tracer. The S.A. of the BET in the plasma of these patients must, therefore, have exceeded that of the glandular hormone more quickly than normal. This could be explained by either a more rapid decrease in the S.A. of the glandular hormone, a more rapid increase in the S.A. of the plasma's hormone, or both. All patients who demonstrated this pattern were hypothyroid, and in three the PBI was found to be subnormal. Since these patients demonstrated a normal or increased concentration of BE1181 in their serum at 24 hours, it may be concluded that the S.A. of their circulating hormonal iodine had increased more rapidly than normal. However, the presence in the plasma of normal or increased concentrations of BEI181 suggests that rather large amounts of radioactive hormone had been released. Furthermore, the hypothyroid state of these patients indicates that the total amount of hormone released by their thyroid tissue per unit time was subnormal. Thus the S.A. of the hormone released by these glands must have been greater than normal. This conclusion, together with the markedly decreased initial uptake of 18l found in the thyroid glands of these patients, indicates that the radioactive hormone formed was minimally "diluted" by preformed, non-radioactive hormone. The total amount of hormone stored by these thyroid glands must, therefore, have been considerably decreased.
A similar decrease in the concentration of BEIl'I between 24 and 72 hours after the administration of the dose was noted in the serum of two pa-tents with thyrotoxicosis made euthyroid by the administration of propylthiouracil. This agent reduces the rate of formation of thyroid hormone (25, 26) but does not diminish, and may rather increase the rate of release of hormone from the gland (27) . In the hyperthyroid patient, this must result in a marked depletion of glandular hormone.
It is apparent that the concentration of BEI38 in the serum does not always accurately reflect the overall rate of hormone formation or release. For any given rate of radioiodine accumulation, depletion of glandular hormone results in an increased release of BEI'81. To the extent that depletion of glandular hormone occurs in patients with thyrotoxicosis, the sensitivity of the test in detecting the hyperthyroid state is increased. However, when depletion of glandular hormone occurs in patients who are not thyrotoxic, the concentration of BEIP'3 in the serum does not correlate well with the clinical state. Two cases of postoperative myxedema demonstrating this phenomenon have recently been reported (28) .
It is possible to evaluate further the manner in which the amount of glandular hormone influences the concentration of BEI'81 in the serum. It will be assumed that the maximal accumulation of radioiodine within the thyroid gland is instantaneous, and that within the first three days after the administration of the tracer, peripheral utilization of released radioactive hormone is negligible. (1) At any time, and for any value of V and A,, the concentration of BEI'81 in the serum will depend upon the rate of turnover of glandular hormone (r). Therefore, at any given rate of hormone manufacture, decreases in the quantity of glandular hormone increase the concentration of BEI181 in the serum by increasing the rate of turnover of hormone within the thyroid gland.
Unlike the thyroid tissue of patients designated as having thyroidal inactivity, that of the patients who had been thyroidectomized is characterized by a high rate of turnover of glandular hormone. It is not known whether, in these patients the remaining thyroid tissue is normal or neoplastic in character. If it were the latter, then the increased turnover rate could be the result of an inability of the tissue to store iodine because of a structural characteristic, such as absence of follicles (29) . It is more likely, however, that the increased turnover rates reflect an intense stimulation of the residual thyroid tissue by thyrotropin (30) . In the latter instance, the failure of the residual tissue to maintain a euthyroid state could result solely from an inadequate glandular mass. In either case, attempts to alter the function of these thyroidal remnants in such a manner as to make possible therapy with radioactive iodine might well be directed towards increasing the thyroidal storage of hormone as well as increasing the avidity for iodine.
Equation 1 suggests that it may be possible to evaluate the rate of turnover of glandular hormone by examining the relationship between the BEI181 and the initial accumulation of radioiodine within the thyroid gland. From equation 1, the slope of the curve representing the relationship between these two functions may be described as
(1 -e-rt) dAo V radioactive iodine has been described previously by the following equation (32) : Uptake = 100 X thyroidal iodide clearance (C*) thyroidal clearance (Ct) + renal clearance (Cr) (4) Therefore, from equations 3 and 4, Uptake = 1 00 (BEI")1) =_ Ct (5) .09 + (BE1131) -Ct + Cr (5 (2) For any value of t, the slope will be a straight line, provided that both V and r are constant. Figure 2 illustrates the relationship observed in the present study between the concentration of BE1181 in the serum 72 hours after the administration of the tracer and the 24-hour thyroidal uptake. The values displayed by patients with thyroidal carcinoma, although shown on the chart, are not included in the calculations made from this figure. In each of the other patients, the observed 24-hour thyroidal uptake of radioiodine is "corrected" for the amount of radioactive hormone which has been released by this time. This correction is made by adding to the observed uptake the product of the 24-hour concentration of BEI131 in the serum and an assumed volume of distribution of BEI131 of 24 liters (27) . The curve shown is the visual best fit to a series of points representing the average value of all patients within each 10 per cent uptake-interval. Rather than following a straight line, the slope of the curve rises sharply as the uptake approaches 100 per cent. Since the volume of distribution of thyroid hormone apparently does not differ among patients with varying states of thyroidal function (27) , equation 2 indicates that as the maximal uptake increases, the rate of turnover of glandular hormone increases. This conclusion is in accord with direct measurements, which reveal an increased rate of release of hormone from thyrotoxic glands (31) .
The curve shown in Figure 2 is described by the equation Uptake = 100 (BE1l3l) 3 .09 + (BEI'') (3) However, the relationship between the thyroidal rate of clearance of plasma iodide and the uptake of .09 Ct (BE11'3) = *Cr (6) If the average normal rate of renal clearance of iodide is assumed to be 2.0 liters per hour (33) , (BEI1) = .045 Ct (7) where Ct = thyroidal iodide clearance rate (liters per hour). The BEI111 concentration in the serum of patients with hyperthyroidism, euthyroidism, and thyroidal inactivity, therefore, appears to be directly proportional to the thyroidal rate of clearance of plasma radioiodide. This conclusion is in accord with the a priori assumption that the thyroidal rate of accumulation of iodide is equal to the rate of release of hormonal iodine. Employing equation 7, and the average normal value for the BEI131 found in the present study, a thyroidal clearance rate of 0.78 liters per hour may be derived, which is in accord with direct measurements of this function (33) (34) (35) age normal daily production of thyroxine is ap-radioactivity of circulating thyroxine, and has proximately 70 mcg. daily (27) . The hormone been applied to the study of the concentration of content of the average normal thyroid gland can, BEI'81 in the serum of 109 patients with various therefore, be estimated to be approximately 7000 states of thyroidal function. mcg., which value agrees closely with those ob-2. These results have been correlated with the tained by direct chemical analysis (36, 37 
